New drug tested to fight uncontrollable sleepiness
NCT ID NCT06961266
Summary
This early-stage study is testing a new drug called JZP441 to see if it can help adults with narcolepsy type 1 stay awake during the day. It will involve a small group of 8 participants to check how safe the drug is, how well it works, and how the body processes it. The main goal is to see if it improves the ability to stay awake in a quiet, dark room compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGAtlanta, Georgia, 30328, United States
-
Clinical Trial Site
RECRUITINGCincinnati, Ohio, 45245, United States
-
Clinical Trial Site
RECRUITINGColumbia, South Carolina, 29201, United States
-
Clinical Trial Site
RECRUITINGAustin, Texas, 78731, United States
Conditions
Explore the condition pages connected to this study.